Selected publications:

Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton M-P, Grousselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y and Amselem S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J. Clin. Invest. 116(3): 760-768 (2006). See Commentary pp 637-41.

Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton M-P, Le Bouc Y, Epelbaum J and Amselem S. Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J. Clin. Endocrinol. Metab. 94(11): 4334-41 (2009).

Pantel J, Williams SY, Mi D, Sebag JA, Corbin JD, Weaver CD and Cone RD. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP Assay. Eur. J. Pharm. 660(1): 139-47 (2011).

Boraska V, Franklin, CS, Floyd, JAB, Thornton, LM, Huckins, LM, Southam and coll. A genome-wide association study of anorexia nervosa. Mol. Psychiatr. 19(10): 1085-1094 (2014).

Chebani Y, Marion C, Zizzari, P, Chettab K, Pastor M, Korostelev M, Geny D, Epelbaum J, Tolle V, Morisset S and Pantel J. Enhanced responsiveness of GhsrQ343X rats to ghrelin results in enhanced adiposity without increased appetite. Sci. Signal. 9, ra39 (2016). See Focus fs6.

Marion C, Zizzari P, Denis RGP, Hassouna R, Chebani Y, Leste-Lasserre T, Doat H, Le Pen G, Cota D, Noble F, Luquet S, and Pantel J. The GhsrQ343X allele favors the storage of fat by acting on nutrient partitioning. J Endocrinol. 251(3): 181–194 (2021).